Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'p53 and mdm2 proteins interaction inhibitor racemic'

Search results for: 'p53 and mdm2 proteins interaction inhibitor racemic'

Items 1-10 of 46

Page
per page
  1. VX-11e
    A3931 VX-11e
     5 Citation
    Target: ERK
    Summary: ERK inhibitor
      ≥25 mg/mL
  2. JNK-IN-7
    A3519 JNK-IN-7
    Target: JNK
    Summary: Selective JNK inhibitor
      ≥24.7 mg/mL
  3. PF-3644022
    B5549 PF-3644022
    Target: MK2
    Summary: Potent and Selective MK2 inhibitor
      <14.98 mg/mL
  4. PD 169316
    A8689 PD 169316
    Target: p38
    Summary: P38 MAPK inhibitor
      insoluble in EtOH; insoluble in H2O; ≥15.3 mg/mL
  5. XMD8-92
    A3943 XMD8-92
    Target: ERK
    Summary: BMK1/ERK5 inhibitor
      ≥23.75 mg/mL
  6. SB 203580
    A8254 SB 203580
     9 Citation
    Target: p38|PKB
    Summary: P38 MAP kinase inhibitor
      insoluble in H2O; ≥18.872 mg/mL
  7. PLX-4720
    A3016 PLX-4720
     1 Citation
    Target: Raf
    Summary: BRAF kinase inhibitor
      ≥20.69 mg/mL
  8. XMD17-109
    A3942 XMD17-109
    Target: ERK
    Summary: ERK-5 inhibitor
      ≥31.95 mg/mL
  9. Dabrafenib Mesylate (GSK-2118436)
    A3347 Dabrafenib Mesylate (GSK-2118436)
    Target: Raf
    Summary: Inhibitor of BRAF(V600) mutants
      ≥30.75 mg/mL
  10. SB 203580 hydrochloride
    B1285 SB 203580 hydrochloride
    Target: p38
    Summary: Specific p38-MAPKs inhibitor
      insoluble in EtOH; insoluble in H2O; ≥20.7 mg/mL

Items 1-10 of 46

Page
per page